PARK7 and Parkinson disease: Found decreased DJ-1 levels in the CSF of PD patients. Method demonstrated 90% sensitivity and 70% specificity for PD vs. controls (≥65 yrs), and 92% sensitivity and 55% specificity for PD vs. AD (≥65 yrs).